Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02918422 · ClinicalTrials.gov registry record · NA
Controlled Clinical Study to Determine Novel Health Benefits of Cheese Consumption
A NA study of Metabolic Syndrome X, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT02918422: Completed NA study of Metabolic Syndrome X, sponsored by Ohio State University.
NCT02918422 is a NA study of Metabolic Syndrome X that has completed, run by Ohio State University. The registered enrollment target is 16 participants, below the 71-participant average among 10 other Metabolic Syndrome X trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02918422, a NA study of Metabolic Syndrome X, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the effects of high cheese diets varying in carbohydrate content on markers of disease risk.
Primary Outcome
Blood analysis for Fatty Acid Composition and Lipoproteins will by conducted by Lipid Technologies and Quest Diagnostics, respectively.
Conditions Studied
Interventions
- OTHER Nutritional and Dietary Manipulation
Study Locations (1)
Ohio
- Physical Activity and Education Services - PAES - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-09 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT02918422 record still lists
NCT02918422 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 71-participant average among 10 other Metabolic Syndrome X trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Metabolic Syndrome X appearing as the primary indexed condition, and to 1 intervention - of which Nutritional and Dietary Manipulation is the first listed.
NCT02918422 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02918422 about?
NCT02918422 is a clinical study titled "Controlled Clinical Study to Determine Novel Health Benefits of Cheese Consumption". To determine the effects of high cheese diets varying in carbohydrate content on markers of disease risk.
What is the current status of trial NCT02918422?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2015-09. Estimated completion is 2018-12.
What conditions does trial NCT02918422 study?
This clinical trial studies the following conditions: Metabolic Syndrome X.
What interventions are being tested in trial NCT02918422?
The interventions under investigation include: Nutritional and Dietary Manipulation (OTHER).
Who is sponsoring clinical trial NCT02918422?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02918422 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Syndrome X
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02918422's enrollment target sits among peer trials
16 11th of 10 the lowest of 10 other Metabolic Syndrome X trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolic Syndrome X trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Dietary Amino Acid Profile on Lipoprotein Metabolism, Vascular Reactivity and Inflammatory Markers
COMPLETED · NA
-
Impact of Almond Supplementation on Body Composition in Overweight/Obese Minority Adults
COMPLETED · NA
-
Collaborative Care for Heart Failure Patients With the Metabolic Syndrome
COMPLETED · NA
-
Effects of Resistance and Aerobic Exercise on Cardiovascular Health
COMPLETED · Phase 2
-
Study of Niacin and Rosiglitazone in Dysmetabolic Dyslipidemia
COMPLETED · Phase 4
-
Diurnal Variation of Plasminogen Activator Inhibitor-1
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia